Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis

Citation
B. De Silva et al., Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis, PEDIAT DERM, 17(6), 2000, pp. 480-483
Citations number
17
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC DERMATOLOGY
ISSN journal
07368046 → ACNP
Volume
17
Issue
6
Year of publication
2000
Pages
480 - 483
Database
ISI
SICI code
0736-8046(200011/12)17:6<480:PANAAI>2.0.ZU;2-5
Abstract
Pseudoporphyria is characterized by erythema, blistering, and scarring on s un-exposed skin. Nonsteroidal antiinflammatory drugs (NSAIDs) are implicate d in the etiology of this condition. In a 1-year prospective study of child ren attending the pediatric rheumatology clinic in Edinburgh we found a pre valence of pseudoporphyria of 10.9% in children taking NSAIDs for juvenile idiopathic arthritis. Naproxen was the most commonly implicated NSAID, inde pendent of dosage, Blue/gray eye color was an independent risk factor for t he development of pseudoporphyria, We would advise caution in prescribing n aproxen in these children to prevent disfiguring facial scarring.